Why Analysts Are Backing CVS Health as a Prime S&P 500 Investment This March

New York, Friday, 27 March 2026.
Trading at an attractive valuation, CVS Health has become a top S&P 500 target for late March 2026, bolstered by recent analyst upgrades and a new AI health platform.